Abiomed, Inc. has announced it has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP heart pump. Culminating from five years of research, this approval follows the prior FDA Humanitarian Device Exemption (HDE) received in January 2015 and adds the Impella RP heart pump to Abiomed's platform of PMA approved devices.
Panasonic PhotoMOS® Photovoltaic MOSFET High-Power Drivers
Adam-Tech Wire-to-Board Solutions